Atossa Therapeutics Inc (NASDAQ: ATOS) Surprised Bears With Its Forecast.

In the last trading session, 1.18 million shares of the Atossa Therapeutics Inc (NASDAQ:ATOS) were traded, and its beta was 1.30. Most recently the company’s share price was $1.37, and it changed around -$0.05 or -3.52% from the last close, which brings the market valuation of the company to $171.66M. ATOS currently trades at a discount to its 52-week high of $2.31, offering almost -68.61% off that amount. The share price’s 52-week low was $0.59, which indicates that the current value has risen by an impressive 56.93% since then. We note from Atossa Therapeutics Inc’s average daily trading volume that its 3-month average coming to 1.60 million.

Atossa Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ATOS as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Atossa Therapeutics Inc is expected to report earnings per share of $A.O. Smith Corporation for the current quarter.

Atossa Therapeutics Inc (NASDAQ:ATOS) trade information

Instantly ATOS has showed a red trend with a performance of -3.52% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 55.68% year-to-date, but still down -17.47% over the last five days. On the other hand, Atossa Therapeutics Inc (NASDAQ:ATOS) is -15.95% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $5, which translates to bulls needing to increase their stock price by 72.6% from its current value. Analyst projections state that ATOS is forecast to be at a low of $5 and a high of $5.

Atossa Therapeutics Inc (ATOS) estimates and forecasts

Atossa Therapeutics Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 103.26 percent over the past six months and at a -16.67% annual growth rate that is well below the industry average of 14.60%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 46.61%.